Accordingly, oral administration of celecoxib, which blocks COX-2 activity, effectively mitigated needle biopsy-induced M2φ accumulation, cancer cell EMT, angiogenesis, and pulmonary metastasis [13]. Here, PTGS2 is linked to cancer.